A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers
- Conditions
- Healthy
- Interventions
- Drug: Oxycontine CR 10mgDrug: GL2907
- Registration Number
- NCT01779492
- Lead Sponsor
- GL Pharm Tech Corporation
- Brief Summary
The purpose of this clinical trial is to compare the pharmacokinetic characteristics of GL2907 XL 20mg tablet and Oxycontin CR 10mg tablet.
- Detailed Description
GL2907 XL 20mg tablet is controlled released formulation which is made by GL Pharm Tech.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 24
- 20~45 years old, Healthy Adult Male Subject
- Body Weight ≥ 50kg and Ideal Body Weight ≤ ±20%
- ALT or AST > 1.25 times (Upper Normal Range)
- Total Bilirubin > 1.5 times (Upper Normal Range)
- CPK > 2 times (Upper Normal Range)
- BUN or Creatinine > Normal Range
- Systolic BP > 160mmHg or < 80mmHg, Diastolic BP > 100mmHg or < 50mmHg
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Oxycontine CR 10mg Oxycontine CR 10mg Oxycodone HCl 10mg GL2907 GL2907 Oxycodone HCl 20mg
- Primary Outcome Measures
Name Time Method Cmax,ss 48h Pharmacokinetic of Oxycodone
AUCτ 24h Pharmacokinetic of Oxycodone
- Secondary Outcome Measures
Name Time Method t1/2 48h Pharmacokinetic of Oxycodone
Vz/f 48h Pharmacokinetic of Oxycodone
CL/F 48h Pharmacokinetic of Oxycodone
Tmax 48h Pharmacokinetic of Oxycodone
degree og fluctuation 48h Pharmacokinetic of Oxycodone
(Cmax,ss-Cmin,ss)/Cave,ssswing 48h Pharmacokinetic of Oxycodone
(Cmax,ss-Cmin,ss)/Cmin,ssR 48h Pharmacokinetic of Oxycodone
Accumulation indexCmin,ss 48h Pharmacokinetic of Oxycodone
Cave,ss 48h Pharmacokinetic of Oxycodone
Trial Locations
- Locations (1)
AJOU University Hospital
🇰🇷Suwon, Gyeonggido, Korea, Republic of